Copertina

Hemodynamic markers independent of pulmonary capillary wedge pressure can discriminate between pre and postcapillary exercise‐induced pulmonary hypertension

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Margaret Montovano, Paul J. Scheel, Ilton M. Cubero Salazar, Paul M. Hassoun, Ryan J. Tedford, Steven Hsu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pulmonary Circulation
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH‐CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative—group 3 pulmonary hypertension
di: P. Vitulo, et al.
Pubblicazione: (2024)

Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension
di: Dirk Habedank, et al.
Pubblicazione: (2024)

Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
di: André Carramenha de Góes Hirano
Pubblicazione: (2017)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension
di: Takatoyo Kiko, et al.
Pubblicazione: (2024)

Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study
di: Kathryn T. del Valle, et al.
Pubblicazione: (2024)

Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012–2019)
di: Adam S. Vohra, et al.
Pubblicazione: (2024)

Pulmonary hypertension patient perspectives toward pulmonary rehabilitation
di: Morgan Bailey, et al.
Pubblicazione: (2024)

Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
di: Salaheldin Ahmed, et al.
Pubblicazione: (2024)

Barriers to and facilitators of physical activity in pediatric pulmonary hypertension
di: Catherine M. Avitabile, et al.
Pubblicazione: (2024)

Right ventricular stroke work index in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A retrospective observational study
di: Györgyi Csósza, et al.
Pubblicazione: (2024)

Editorial on “Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension”
di: Lindsay M. Forbes
Pubblicazione: (2024)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
di: Steven D. Nathan, et al.
Pubblicazione: (2024)

The effects of oxygenation on acute vasodilator challenge in pulmonary arterial hypertension
di: Matthew D. Rockstrom, et al.
Pubblicazione: (2024)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
di: Diederik P. Staal, et al.
Pubblicazione: (2024)

Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States
di: Harrison W. Farber, et al.
Pubblicazione: (2024)

Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension
di: Tejaswini P. Reddy, et al.
Pubblicazione: (2024)

PPARγ/ETV2 axis regulates endothelial‐to‐mesenchymal transition in pulmonary hypertension
di: Dong Hun Lee, et al.
Pubblicazione: (2024)

SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation
di: Robert P. Frantz, et al.
Pubblicazione: (2024)

Association of mildly elevated pulmonary vascular resistance with major cardiovascular events in pulmonary hypertension and chronic kidney disease: A retrospective cohort analysis
di: Jose M. Martinez Manzano, et al.
Pubblicazione: (2024)

Nanoparticle delivery of VEGF and SDF‐1α as an approach for treatment of pulmonary arterial hypertension
di: Victoria A. Guarino, et al.
Pubblicazione: (2024)

Safety of inhaled nitric oxide withdrawal in severe chronic pulmonary hypertension
di: Gregorio Miguel Pérez‐Peñate, et al.
Pubblicazione: (2024)

THBS1 mediates hypoxia driven EndMT in pulmonary hypertension
di: Bingming Peng, et al.
Pubblicazione: (2024)

Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertension
di: Adam J. Brownstein, et al.
Pubblicazione: (2024)

Delta‐like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials
di: Casandra E. Besse, et al.
Pubblicazione: (2024)

Extracorporeal membrane oxygenation (ECMO) support for children with pulmonary hypertension: A single‐institutional experience of outcomes
di: Christopher Nemeh, et al.
Pubblicazione: (2024)

Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study
di: Athiththan Yogeswaran, et al.
Pubblicazione: (2024)

Intimal sarcoma of the pulmonary artery presenting as pulmonary embolism
di: María Camila Plata
Pubblicazione: (2017)

Peripheral pulmonary artery aneurysm presenting as a solitary pulmonary nodule
di: Mauro Federico Luis Tamagno
Pubblicazione: (2015)

COPD associated pulmonary hypertension: A post hoc analysis of the PERFECT study
di: Steven D. Nathan, et al.
Pubblicazione: (2024)

Predictors of early mortality after lung transplantation for idiopathic pulmonary arterial hypertension
di: Reda E. Girgis, et al.
Pubblicazione: (2024)

Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review
di: Kadija Hersi, et al.
Pubblicazione: (2024)

Impact of general anesthesia on the echocardiographic assessment of right ventricular function in pediatric patients with pulmonary arterial hypertension
di: Charles T. Simpkin, et al.
Pubblicazione: (2024)

Editorial on “Characteristics and risk profiles of patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension living permanently at >2500 m of high altitude in Ecuador”
di: Samantha Sharma, et al.
Pubblicazione: (2024)

Carnitine consumption and effect of oral supplementation in human pulmonary arterial hypertension: A pilot study
di: Evan L. Brittain, et al.
Pubblicazione: (2024)

Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY)
di: Nika Skoro‐Sajer, et al.
Pubblicazione: (2024)

Tricuspid annular plane systolic excursion in pulmonary hypertension—Moving beyond the sector plane
di: Kenzo Ichimura, et al.
Pubblicazione: (2024)

An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure
di: Elizabeth G. Fenner, et al.
Pubblicazione: (2024)

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with bronchial obstruction by a carcinoid tumor
di: Yuki Monden, et al.
Pubblicazione: (2024)

NT‐pro‐BNP is predictive of morbidity and mortality after pulmonary thromboendarterectomy and is independent of preoperative hemodynamics
di: Emanuel A. Keiler, et al.
Pubblicazione: (2024)

Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertension
di: Justin J. Kochanski, et al.
Pubblicazione: (2024)